Skip to main content
Erschienen in: Strahlentherapie und Onkologie 11/2015

01.11.2015 | Original Article

The use of IMRT in Germany

verfasst von: Dr. rer. nat. Dr. med. Thorsten Frenzel, PD Dr. med. Andreas Krüll

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Intensity modulated radiotherapy (IMRT) is frequently used, but there are no data about current frequency regarding specific tumor sites and equipment used for quality assurance (QA).

Materials and methods

An online survey about IMRT was executed from April to October 2014 by the collaborative IMRT working group (AK IMRT) of the German Association of Medical Physicists (DGMP).

Results

A total of 23 German institutions took part in the survey. Most reports came from users working with Elekta, Varian, and Siemens treatment machines, but also from TomoTherapy and BrainLab. Most frequent IMRT technology was volumetric modulated arc therapy (58.37 %: VMAT/“rapid arc”), followed by step-and-shoot IMRT (14.66 %), dynamic MLC (dMLC: 14.53 %), TomoTherapy (9.25 %), and 3.2 % other techniques. Different commercial hard- and software solutions are available for QA, whereas many institutes still develop their own phantoms. Data of 26,779 patients were included in the survey; 44 % were treated using IMRT techniques. IMRT was most frequently used for anal cancer, (whole) craniospinal irradiation, head and neck cancer, prostate cancer, other tumors in the pelvic region, gynecological tumors (except for breast cancer), and brain tumors.

Discussion

An estimated 10 % of all patients treated in 2014 with radiation in Germany were included in the survey. It is representative for the members of the AK IMRT.

Conclusion

IMRT may be on the way to replace other treatment techniques. However, many scientific questions are still open. In particular, it is unclear when the IMRT technique should not be used.
Literatur
2.
3.
Zurück zum Zitat Popple RA, Balter PA (2014) Because of the advantages of rotational techniques, conventional IMRT will soon become obsolete. Med Phys 41:100601CrossRefPubMed Popple RA, Balter PA (2014) Because of the advantages of rotational techniques, conventional IMRT will soon become obsolete. Med Phys 41:100601CrossRefPubMed
4.
Zurück zum Zitat Dunst J, Willich N, Sack H, Engenhart-Cabillic R, Budach V, Popp W (2014) The QUIRO Study (assurance of quality and innovation in radiooncology): methodology, instruments and practices. Strahlenther Onkol 190:138–148CrossRefPubMed Dunst J, Willich N, Sack H, Engenhart-Cabillic R, Budach V, Popp W (2014) The QUIRO Study (assurance of quality and innovation in radiooncology): methodology, instruments and practices. Strahlenther Onkol 190:138–148CrossRefPubMed
5.
Zurück zum Zitat Gao K, Ding L, Li L (2014) Analysis of clinical efficacy of intensity-modulated radiation therapy and the prognosis factors in advanced cervical cancer. Zhonghua Fu Chan Ke Za Zhi 49:30–35PubMed Gao K, Ding L, Li L (2014) Analysis of clinical efficacy of intensity-modulated radiation therapy and the prognosis factors in advanced cervical cancer. Zhonghua Fu Chan Ke Za Zhi 49:30–35PubMed
6.
Zurück zum Zitat Gandaglia G, Karakiewicz PI, Briganti A, Trinh QD, Schiffmann J, Tian Z et al (2014) Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study. Ann Oncol 25:979–986CrossRefPubMed Gandaglia G, Karakiewicz PI, Briganti A, Trinh QD, Schiffmann J, Tian Z et al (2014) Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study. Ann Oncol 25:979–986CrossRefPubMed
7.
Zurück zum Zitat Jang-Chun L, Jing-Min H, Yee-Min J, Dai-Wei L, Chang-Ming C, Chun-Shu L et al (2014) Comparisons of quality of life for patients with nasopharyngeal carcinoma after treatment with different RT technologies. Acta Otorhinolaryngol Ital 34:241–246PubMedCentralPubMed Jang-Chun L, Jing-Min H, Yee-Min J, Dai-Wei L, Chang-Ming C, Chun-Shu L et al (2014) Comparisons of quality of life for patients with nasopharyngeal carcinoma after treatment with different RT technologies. Acta Otorhinolaryngol Ital 34:241–246PubMedCentralPubMed
8.
Zurück zum Zitat Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127–136PubMedCentralCrossRefPubMed Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127–136PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Tribius S, Bergelt C (2011) Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev 37:511–519CrossRefPubMed Tribius S, Bergelt C (2011) Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev 37:511–519CrossRefPubMed
Metadaten
Titel
The use of IMRT in Germany
verfasst von
Dr. rer. nat. Dr. med. Thorsten Frenzel
PD Dr. med. Andreas Krüll
Publikationsdatum
01.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 11/2015
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-015-0832-4

Weitere Artikel der Ausgabe 11/2015

Strahlentherapie und Onkologie 11/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.